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THE LANCET
International experts recommend concerted attack against infection
Current issues in clinical infection were addressed recently at an 
international meeting entitled “The 
challenge of infectious diseases., the 
European perspective” (Amsterdam., 
Netherlands, Dec 18-19). Principal 
areas covered were molecular 
methods for characterisation and 
tracking of newly (re)emerging 
infections, and the increasing 
problem of antibiotic resistance.
Antibiotic resistance in pathogens 
rapidly evolves in response to the 
environmental pressure of antibiotic 
exposure. Results presented at the 
meeting indicate that antibiotic- 
resistant bacteria are less prevalent 
in the Netherlands than in other 
European countries— due perhaps 
to the careful use of antibiotics. 
Rigorous implementation of hospital 
hygiene policies is generally accepted 
practice in the Netherlands and 
broad-spectrum antimicrobial agents 
are strictly reserved for “bad times”.
In the USA, profound changes in
hospital practice (eg, shortened hos­
pital stay, reductions in trained staff) 
may be a major contributor to 
the spread of new infections and 
antibiotic resistance, said John 
McGowan (Atlanta^ USA). The 
concept of a Hospital Epidemiology 
Service, encompassing all the disci­
plines required to control infection, 
was raised by several delegates. But, 
whether a reduction in antibiotic use 
in hospitals would influence resis­
tance profiles is not yet clear since 
resistance genes are in the bacterial 
population and genetic exchange is 
common. McGowan’s report that 
control of vancomycin use in a hospi­
tal setting can reduce the carriage of 
vancomycin-resistant enterococci by 
60% gave some scope for optimism.
The use of molecular typing has 
enabled the tracking of mycobacterial 
strains in the Netherlands. The data 
suggest that isotiiazid-resistant 
strains are less transmissible than 
streptomycin-resistant mycobacteria,
noted Jan van Emden (Bilthoven, 
Netherlands). Molecular techniques 
have also permitted a better under­
standing of the Dutch HIV-1 
epidemic, reported Jaap Goudsmit, 
(Amsterdam, Netherlands). Genetic 
analysis of the HIV-1 V3 loop has 
revealed that HIV-1 subtypes found 
in intravenous drug users are related 
to US HIV-1 subtypes. 1976 and 
1980 have also been identified as 
start dates for the HIV-1 epidemic in 
the Dutch homosexual population 
and drug users, respectively.
Great advances are being made in 
establishing and strengthening the 
European microbiological surveil­
lance system. These include: the 
organisation of an efficient commu­
nication network between national 
centres; an increased use of common 
microbiological and epidemiological 
methods; and the establishment of a 
European training network.
George E Griffin, Jos W M van der Meer
Elderly patients benefit 
from (3-blockers
Underprescribing (3-blockers to elderly patients after acute 
myocardial infarction (AMI) is associ­
ated with adverse outcomes, report 
Stephen Soumerai and colleagues 
(Boston, USA; JAMA  1997; 277: 
115-21).
(3-blockers improve survival after 
AMI by 20-40%, and decrease subse­
quent cardiac morbidity by the same 
amount. 80% of deaths after AMI 
occur among elderly patients, but it is 
not known how often (3-blockers are 
prescribed to this group.
The researchers retrospectively 
studied 5332 elderly survivors of 
AMI. Only 21% of those eligible were 
prescribed (3-blockers. But the propor­
tion of patients given calcium-channel 
blockers increased after AMI from 
23% to 49%. The use of |3-blockers 
decreased mortality by 43%) and car­
diac re-admissions by 22% during the
2-year follow-up. Patients receiving 
calcium-channel blockers were twice 
as likely to die as those on (3-blockers.
Soumerai speculates that undue 
concern about si de-effects, or exten­
sive marketing of calcium-channel 
blockers, may have fostered negative 
attitudes towards p-blockers, even 
though most physicians are well aware 
of their potential survival benefits. □
Team approach improves triage of chest pain
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To stay or not to
A  multidisciplinary team has developed a strategy for the 
rapid triage of patients with chest 
pain. Their approach has helped to 
prevent unneces­
sary hospitalisa­
tion of low-risk 
patients and in­
appropriate dis­
charge of people 
with undiagnosed 
heart attacks.
US emergency 
departments m is­
takenly discharge 
2-10% of patients 
with chest pain 
who are in fact having an acute 
myocardial infarction (AMI). 
Mortality among these individuals 
is nearly twice that of patients with 
AMI who are admitted to hospital. 
To avoid potentially lethal errors, 
liberal admission policies at a cost 
of approximately US $10-$ 13 billion 
per year have been instigated.
The study’s lead author, James 
Tatum (chair of nuclear medicine 
and director of nuclear cardiology 
at Virginia Commonwealth Univer­
sity Richmond, USA), says* “We 
asked, how quickly can we get these 
people through the system in the 
most cost-effective way?”
An acute cardiac team that
included cardiologists, emergency 
personnel, nurses, and imaging 
specialists developed and 
administered an algorithm to
everyone arriving 
at the emergency 
department with 
chest pain. All 
the patients were 
clinically evalu- 
g ated on presenta-
2 tion and assigned 
i  to one of the five 
|  risk categories
# defined by the 
stay triage algorithm.
The strategy also 
included 1 year of follow-up (Ann 
Emerg Med  1997$ 29: 116-25).
In all, 1187 patients were 
included in the study, and patients 
with abnormal imaging findings 
had a significantly higher risk of 
AMI and subsequent death than 
those with normal findings.
According to Tatum, the team 
approach, the development of 
treatment pathways, and follow-up 
were the most important elements 
of the study. “The personnel, the 
commitment, and the sharing of 
information are what’s important”, 
he said.
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